by: Parent Project Muscular DystrophyPositive Data from Summit’s PhaseOUT DMD Ezutromid Clinical Trial (February 2018)
Parent Project Muscular Dystrophy and Action Duchenne hosted a webinar update on February 7, 2018 on the recent report that Summit has announced positive 24-week interim results from the open-label Phase 2 proof of concept clinical trial, PhaseOut DMD.
